Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  Allemagne

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Motto: Fortschritt gemeinsam gestalten

Der Kongress umfasst kompakte und intensive Bestandsaufnahme der aktuellen Forschungsergebnisse und Situation in der Onkologie in Deutschland.

Beleuchtet werden aktuelle und künftige medizinische Entwicklungen und neue Therapien für alle Tumorentitäten. Zudem Schwerpunkte und Fragen zur Gesundheitspolitik.

Kongress- und Kulturmanagement GmbH

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Frankfurt & via Livestream,03.-04.05.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Tél.: [+49 (0) 6192 47072 00];     Email.: info@fomf.de

Formation médicale continue (FMC),    Hématologie

ITOC is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Wolfgang Wilmanns Stiftung (WWS), the German Cancer Consortium (DKTK), the Chinese American Hematologist and Oncologist Network (

The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

Event Secretariat;     Tél.: [+431405138318];     Email.: itoc@wma.co.at

Basic Tumor Immunology, New Targets and New Leads, Exploiting B Cells and Other Cell Types, Microbiome, Adjuvant vs Neoadjuvant IO Treatment, Combination Therapies, Immuno-Monitoring, Reaching New Grounds in Cellular Therapies, Cell therapies in Hematologic Oncology, Cell Therapies in Solid Oncology

Immunologie et Allergie,    Médecine translationnelle, essais cliniques

The European Association for the Study of the Liver (EASL)

After years of stagnation, a paradigm shift has occurred in the therapy of hepatobiliary malignancies: immune-oncology based combinations and new options in the second line revolutionized the treatment of patients with hepatocellular carcinoma, while biliary cancers – endowed with a genuinely high frequency of targetable lesions – evolved as a role model for precision oncology. These developments have generated a growing need for clinicians, pathologists and translational scientists to gain an in-depth understanding of diagnostic and clinical strategies that facilitate the implementation of individualized treatment concepts in hepato-oncology. The EASL school on “Personalized medicine in hepatobiliary malignancies” transitions fluently between molecular pathology diagnostics and clinical translation and provides room and space to foster interdisciplinary exchange. Under the guidance of experts in the field (liver pathologists, clinical and basic hepato-oncologists), students will gain confidence in the interpretation of molecular diagnostics reports and perform group work to build innovative treatment concepts for patients with hepatobiliary cancers. In addition to short lectures, panel discussions and a “live microscopy session”, the school features thought-provoking discourses on the diagnostic and therapeutic future of hepato-oncology.

Deutsche Gesellschaft für Radioonkologie e.V. (German Society for Radiation Oncology)

At the annual congress of the German Society of Radiation Oncology (DEGRO), all those working in radiation oncology have the opportunity to discuss all aspects important for the development of radiation oncology in a concentrated form and thus come to a broad exchange of knowledge.

Kongressorganisation;     Tél.: [+49 3643 2468-126];     Email.: degro-registrierung@KUKM.DE

radiooncology, radiotherapy, nuclear medicine, oncology, radiology, radiation, hematology, medicine, nuclear physicians, medical technologist for radiology

Radiologie, médecine nucléaire et radiothérapie,    Hématologie

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Hamburg & via Livestream, 21.-22.06.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Tél.: [+49 (0) 6192 47072 00];     Email.: info@fomf.de

Formation médicale continue (FMC),    Hématologie

European Society for Medical Oncology (ESMO)

Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present very impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern. The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Tél.: [+41 (0)91 973 19 62];     Email.: gicongress@esmo.org

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Pancreatic Cancer, Biliary Tract Cancer, Neuroendocrine Tumors, Colon Cancer, Rectal Cancer, GIST, Anal Cancer, Gastrointestinal Cancers

Gastro-entérologie,    Médecine translationnelle, essais cliniques

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email.: conferencemarketing@conventus.de